AAV Success Studies | Retinal Dystrophy | Spinal Muscular Atrophy

Cure One, Cure Many: The Case of Spinal Muscular Atrophy | American Brain FoundationПодробнее

Spinal Muscular Atrophy: AVXS-101 Gene Transfer TherapyПодробнее

Spinal Muscular Atrophy 2020: Occupational Therapy Best Practices for Non-SittersПодробнее

Lessons Learned from SMA for DMDПодробнее

Developing therapies for muscular dystrophy and spinal muscular atrophyПодробнее

MDUK Muscles Matter 2022: Spinal Muscular Atrophy (adult focus)Подробнее

2020 Science Writers' Boot Camp: New Treatments for Spinal Muscular Atrophy—Neurodegenetic DiseasesПодробнее

Gene Therapy Data and Implications of AAV9 AntibodiesПодробнее

Understanding Spinal Muscular Atrophy (SMA)Подробнее

Spinal Muscular Atrophy: Navigating Recent Therapeutic AdvancesПодробнее

Richard Finkel, AAN 2018 – Spinal muscular atrophy (SMA) is a treatable neurodegenerative diseaseПодробнее

Life Saving Spinal Muscular Atrophy (SMA) Treatment | Sam's StoryПодробнее

Spinal Muscular Atrophy 2020: Occupational Therapy Best Practices for WalkersПодробнее

Spinal Muscular AtrophyПодробнее

Emerging Gene Therapies for Spinal Muscular AtrophyПодробнее

Four or More Copies of SMN2 in Patients with Spinal Muscular Atrophy: Treat or Wait?Подробнее

Genetic Counseling: Retinal Dystrophy Clinic at UPMC | UPMC On TopicПодробнее

Introduction to Spinal Muscular AtrophyПодробнее

Altering the Natural History of Spinal Muscular AtrophyПодробнее